Author

K. K. Kim

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:bacteria (other)· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Abramson· 1 shared A. Awada· 1 shared A. Jones· 1 shared A. Zhang· 1 shared A.-L. Thomas· 1 shared B. Jeong· 1 shared C. Baker· 1 shared C. Jackson· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Abramson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Spiral NeuroString: High-Density Soft Bioelectronic Fibers for Multimodal Sensing and Stimulation

M. Khatib, E. T. Zhao, S. Wei, A. Abramson, E. B. Bishop, C.-H. Chen, A.-L. Thomas, C. Xu, J. Park, Y. Lee, R. Hamnett, W. Yu, S. E. Root, L. Yuan, D. Chakhtoura, , Z. Bao

This paper introduces Spiral NeuroString, high-density soft bioelectronic fibers for multimodal sensing and stimulation, demonstrating their use in GI motility mapping, serotonin sensing, and brain recordings.

bioRxiv · Oct 2, 2023Bioengineering

Staphylococcus aureus does not synthesize arginine from proline under physiological conditions

T. Bae, B. Jeong, M. A. Shah, E. Roh, K. K. Kim, I. Park

This study shows that Staphylococcus aureus cannot synthesize arginine from proline under physiological conditions due to low P5C concentrations, not CCR repression.

bioRxiv · Jan 12, 2022Microbiology

Septins disruption controls tumor growth and enhances efficacy of Herceptin

R. K. Singh, K. K. Kim, N. Khazan, R. B. Rowswell_Turner, C. Laggner, A. Jones, P. Srivastava, V. Hovanesian, L. Lamere, T. Conley, R. Pandita, C. Baker, J. R. Myers, E. Prichett, A. Awada, , R. Moore

The paper develops UR214-9, a compound that disrupts septin filaments in cancer cells, inhibiting growth of HER2+ tumors and enhancing Herceptin efficacy.

bioRxiv · Feb 19, 2020 · PreprintCancer Biology